Effects of myxedema on the renal diluting and concentrating mechanism.
D000328:Adult; D000368:Aged; D005260:Female; D005919:Glomerular Filtration Rate; D006801:Humans; D007671:Kidney Concentrating Ability; D007677:Kidney Function Tests; D007678:Kidney Glomerulus / Q000503:physiopathology*; D007684:Kidney Tubules / Q000503:physiopathology*; D008175:Lung Neoplasms / Q000503:physiopathology; D008297:Male; D008353:Mannitol; D008875:Middle Aged; D009230:Myxedema / Q000188:drug therapy / Q000503:physiopathology*; D009318:Natriuresis; D009994:Osmolar Concentration; D014284:Triiodothyronine / Q000627:therapeutic use; D014667:Vasopressins / Q000378:metabolism; D014882:Water-Electrolyte Balance
D014284:Triiodothyronine; D014667:Vasopressins; D008353:Mannitol